What is CRSP's current stock price?

As of now, CRSP is trading at $51.58, with a daily change of -1.13%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CRSP Stock Analysis & IQ Rating | CRISPR Therapeutics

CRSP

CRISPR Therapeutics

$51.58

-$0.59 | -1.13%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$78.48

MKT CAP

$4.92B

52W Low

$30.06

VOL

$1.41M

P/E Ratio

N/A

AVG VOL

$2.45M

RSI

40.12

TREND

Downtrend

Latest Comments

Comeback Kings Bounce Back $MRVL $HPP $CRSP $HKD all hit the floor today but climbed back like pros

November 28, 2025 12:32 PM

CRSP Stock IQ

Login to see CRISPR Therapeutics (CRSP) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CRSP Target Price

Login to display

Strengths

CRSP Rewards

Earnings are forecast to grow

CRSP Rewards

Upgraded on attractively valued

CRSP Rewards

Investors confidence is positive

CRSP Price Performance

$63.99 (-19.39%)

$52.74 (-2.20%)

$60.08 (-14.15%)

$47.78 (+7.95%)

1year

6month

3month

1month

CRSP Risk Level

CRSP has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

CRSP Analysts Opinion

CRSP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CRSP Analysts Opinion

CRSP Analysts opinion is positive and also has improved from the past 3 months

CRSP Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

88%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

CRSP Street Sentiment

CRSP Street Sentiment is bullish and have positive views on the near-term outlook

CRSP Performance Sentiment

Sentiments overview associated with CRSP events and the stock performance.

88%

12%

Positive

Negative

15 out of 17
events present

2 out of 17
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$53.30

Resistance
Price

$49.29

Current Price Range

$72.82

Show methods +

Linked to CRSP

IQ

Close Price

Change

VCEL

4.04

37.65

-3.01%

IBRX

4.14

2.09

-9.13%

CLDI

3.50

1.43

-2.05%

BNTX

3.32

96.11

-1.31%

AMGN

4.03

338.36

+0.26%

CRSP Latest Analysis +

CRISPR Therapeutics: CTX310 De-Risks CASGEVY Disappoints Amid Takeover Rumors.

Tue Dec 2, 2025

$51.58 | -1.13%

Activity

Crispr Therapeutics pares loss amid takeover speculation.

Mon Dec 1, 2025

$52.17 | -2.43%

Activity

What CRISPR Therapeutics (CRSP) Latest Trial Results Mean for Investors. CRISPR Therapeutics AG (NASDAQ:CRSP) is among the top 10 stocks to buy from Cathie Woods stock portfolio. CRISPR made up roughly 3.8% of ARK Investments disclosed equity portfolio at third-quarter-end with a position valued at approximately $634 million. ARK decreased its exposure slightly in Q3 reducing its holdings from 10.18 million to 9.79 million shares. As [….]

Mon Dec 1, 2025

$52.17 | -2.43%

Potential

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It. CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.

Tue Nov 25, 2025

$53.57 | +4.53%

Activity

Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance.

Tue Nov 25, 2025

$53.57 | +4.53%

Activity

RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50 Keeps Sector Perform. CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11 RBC Capital raised its price target for CRISPR Therapeutics AG (NASDAQ:CRSP) stock from $42 to $50. The firm kept the Sector Perform rating on the shares. The analysts noted that CASGEVY CRISPRs leading product missed [….]

Tue Nov 18, 2025

$53.47 | -3.34%

Potential

Notable Monday Option Activity: CRSP STZ AVGO. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in CRISPR Therapeutics AG (Symbol: CRSP) where a total of 12088 contracts have traded so far representing approximately 1.2 million underlying shares. That amounts to ab

Mon Nov 17, 2025

$55.32 | +5.31%

Momentum

Crispr Therapeutics gains amid takeover speculation.

Mon Nov 17, 2025

$55.32 | +5.31%

Activity

DYAI: Purchase Orders Rolling In. By Dyadic Applied BioSolutions Inc. (NASDAQ:DYAI) announced third quarter 2025 results on November 12th 2025 and held a conference call to discuss them after that days market close. The remarkable takeaway from the press release is that Dyadic has a diversified set of revenue opportunities that may all contribute to the topline in the next few months. Customers have submitted purchase orders for C1 and Dapibus produced proteins including cell culture media and m

Fri Nov 14, 2025

$52.44 | +2.66%

Activity

Citigroup Maintains CRISPR Therapeutics (CRSP) Buy Recommendation. Fintel reports that on November 12 2025 Citigroup maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a Buy recommendation. Analyst Price Forecast Suggests 57.77% Upside

Thu Nov 13, 2025

$51.11 | -2.07%

Rating

FAQ About CRSP Stock Insights

What is CRSP current stock price?

What are CRSP stock strengths?

What is CRSP Risk Level?

What is CRSP market cap and volume?

What is CRSP current Stock IQ?

Should I buy CRSP stock right now?

Is CRSP a Strong Buy right now?

What does a 'Strong Buy' rating mean for CRSP?

What does a 'Strong Sell' rating mean for CRSP?

What factors influence CRSP's Stock IQ?

Explore our CRSP Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CRSP Stock Strategies
Effective Risk Management

FIND US ON

Receive our CRSP Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CRSP

CRISPR Therapeutics

Current Price

$51.58

-$0.59 | -1.13%

52W High

$78.48

MKT CAP

$4.92B

52W Low

$30.06

VOL

$1.41M

P/E Ratio

N/A

AVG VOL

$2.45M

RSI

40.12

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

CRSP Rewards

Earnings are forecast to grow

CRSP Rewards

Upgraded on attractively valued

CRSP Rewards

Investors confidence is positive

Linked to CRSP

Symbol

IQ

Close

Change

VCEL

4.04

37.65

-3.01%

IBRX

4.14

2.09

-9.13%

CLDI

3.50

1.43

-2.05%

BNTX

3.32

96.11

-1.31%

AMGN

4.03

338.36

+0.26%

Latest Comments

Comeback Kings Bounce Back $MRVL $HPP $CRSP $HKD all hit the floor today but climbed back like pros

November 28, 2025 12:32 PM

CRSP Price Performance

$63.99 (-19.39%)

$52.74 (-2.20%)

$60.08 (-14.15%)

$47.78 (+7.95%)

1year

6month

3month

1month

CRSP Analysts Opinion

CRSP Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

CRSP Analysts Opinion

CRSP Analysts opinion is positive and also has improved from the past 3 months

CRSP Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

88%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

CRSP Street Sentiment

CRSP Street Sentiment is bullish and have positive views on the near-term outlook

CRSP Risk Level

CRSP has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

CRSP Performance Sentiment

Sentiments overview associated with CRSP events and the stock performance.

88%

12%

Positive

Negative

15 out of 17
events present

2 out of 17
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$53.30

Resistance
Price

$49.29

Current Price Range

$72.82

Show methods +

CRSP Stock IQ

Login to unlock CRISPR Therapeutics (CRSP) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CRSP Latest Analysis

CRISPR Therapeutics: CTX310 De-Risks CASGEVY Disappoints Amid Takeover Rumors.

Tue Dec 2, 2025

$51.58 | -1.13%

Activity

Crispr Therapeutics pares loss amid takeover speculation.

Mon Dec 1, 2025

$52.17 | -2.43%

Activity

What CRISPR Therapeutics (CRSP) Latest Trial Results Mean for Investors. CRISPR Therapeutics AG (NASDAQ:CRSP) is among the top 10 stocks to buy from Cathie Woods stock portfolio. CRISPR made up roughly 3.8% of ARK Investments disclosed equity portfolio at third-quarter-end with a position valued at approximately $634 million. ARK decreased its exposure slightly in Q3 reducing its holdings from 10.18 million to 9.79 million shares. As [….]

Mon Dec 1, 2025

$52.17 | -2.43%

Potential

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It. CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.

Tue Nov 25, 2025

$53.57 | +4.53%

Activity

Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance.

Tue Nov 25, 2025

$53.57 | +4.53%

Activity

RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50 Keeps Sector Perform. CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11 RBC Capital raised its price target for CRISPR Therapeutics AG (NASDAQ:CRSP) stock from $42 to $50. The firm kept the Sector Perform rating on the shares. The analysts noted that CASGEVY CRISPRs leading product missed [….]

Tue Nov 18, 2025

$53.47 | -3.34%

Potential

Notable Monday Option Activity: CRSP STZ AVGO. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in CRISPR Therapeutics AG (Symbol: CRSP) where a total of 12088 contracts have traded so far representing approximately 1.2 million underlying shares. That amounts to ab

Mon Nov 17, 2025

$55.32 | +5.31%

Momentum

Crispr Therapeutics gains amid takeover speculation.

Mon Nov 17, 2025

$55.32 | +5.31%

Activity

DYAI: Purchase Orders Rolling In. By Dyadic Applied BioSolutions Inc. (NASDAQ:DYAI) announced third quarter 2025 results on November 12th 2025 and held a conference call to discuss them after that days market close. The remarkable takeaway from the press release is that Dyadic has a diversified set of revenue opportunities that may all contribute to the topline in the next few months. Customers have submitted purchase orders for C1 and Dapibus produced proteins including cell culture media and m

Fri Nov 14, 2025

$52.44 | +2.66%

Activity

Citigroup Maintains CRISPR Therapeutics (CRSP) Buy Recommendation. Fintel reports that on November 12 2025 Citigroup maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a Buy recommendation. Analyst Price Forecast Suggests 57.77% Upside

Thu Nov 13, 2025

$51.11 | -2.07%

Rating

Discover CRSP Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CRSP. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CRSP Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CRSP Stock trends

CRSP Stock performance

CRSP Stock analysis

CRSP investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRSP

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRSP

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

CRSP Stock Analysis & IQ Rating | CRISPR Therapeutics

CRSP Stock IQ

CRSP Target Price

CRSP Risk Level

CRSP Analysts Opinion

CRSP Street Sentiment

CRSP Performance Sentiment

Technical Price Levels

Explore our CRSP Stock insights

Receive our CRSP Daily Alerts

Latest Comments

Latest Comments

CRSP Street Sentiment

CRSP Risk Level

Technical Price Levels

Discover CRSP Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CRSP. We're here to help you make informed investment decisions today.

Receive our CRSP Daily Alerts

CRSP Runner Alarm